Diagnosis of insulin resistance and associated syndromes: the spectrum from the metabolic syndrome to type 2 diabetes mellitus

被引:24
作者
Simonson, GD
Kendall, DM
机构
[1] Int Diabet Ctr, Minneapolis, MN 55416 USA
[2] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
关键词
cardiovascular disease; insulin resistance; insulin resistance syndrome; metabolic syndrome; type; 2; diabetes;
D O I
10.1097/00019501-200512000-00002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insulin resistance is a common underlying physiologic abnormality associated with central obesity, type 2 diabetes and cardiovascular disease. Clinically, its hallmark markers of hypertension, glucose intolerance and dyslipidemia have been grouped into associated syndromes of insulin resistance. Insulin resistance is now considered a useful marker of clinical risk and a target for therapeutic intervention. While the criteria for diagnosis of syndromes related to insulin resistance have been established, the clinical diagnosis of insulin resistance remains a significant challenge. As more clinicians focus on the management of insulin resistance in patients with cardiovascular disease, type 2 diabetes and other syndromes of insulin resistance, its diagnosis will take on increasing importance. This review focuses on the current definition and diagnosis of insulin resistance and associated syndromes.
引用
收藏
页码:465 / 472
页数:8
相关论文
共 50 条
  • [31] Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome - The insulin resistance atherosclerosis study
    Hanley, AJG
    Karter, AJ
    Williams, K
    Festa, A
    D'Agostino, RB
    Wagenknecht, LE
    Haffner, SM
    CIRCULATION, 2005, 112 (24) : 3713 - 3721
  • [32] Metabolic Syndrome and Type-1 Diabetes Mellitus: Prevalence and Associated Factors
    Chillaron, Juan J.
    Flores-Le-Roux, Juana A.
    Goday, Alberto
    Benaiges, David
    Carrera, Maria J.
    Puig, Jaume
    Cano-Perez, Juan F.
    Pedro-Botet, Juan
    REVISTA ESPANOLA DE CARDIOLOGIA, 2010, 63 (04): : 423 - 429
  • [33] Associations of iron markers with type 2 diabetes mellitus and metabolic syndrome: Results from the prospective SHIP study
    Pitchika, Anitha
    Schipf, Sabine
    Nauck, Matthias
    Doerr, Marcus
    Lerch, Markus M.
    Felix, Stephan B.
    Markus, Marcello Ricardo Paulista
    Voelzke, Henry
    Ittermann, Till
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 163
  • [34] Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus
    DePaula, A. L.
    Macedo, A. L. V.
    Rassi, N.
    Vencio, S.
    Machado, C. A.
    Mota, B. R.
    Silva, L. Q.
    Halpern, A.
    Schraibman, V.
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2008, 22 (12): : 2670 - 2678
  • [35] Insulin resistance and carotid atherosclerosis in patients with type 2 diabetes
    Park, Seok Won
    Kim, Soo Kyung
    Cho, Yong-Wook
    Kim, Dae Jung
    Song, Young-Duk
    Choi, Young Ju
    Huh, Byung Wook
    Choi, Sung Hee
    Jee, Sun Ha
    Cho, Mi Ae
    Lee, Eun Jig
    Huh, Kap Bum
    ATHEROSCLEROSIS, 2009, 205 (01) : 309 - 313
  • [36] Metabolic Effects of Testosterone Therapy in Men with Type 2 Diabetes and Metabolic Syndrome
    Hackett, Geoffrey
    SEXUAL MEDICINE REVIEWS, 2019, 7 (03) : 476 - 490
  • [37] Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome
    Davies, Michael J.
    Merton, Katherine W.
    Vijapurkar, Ujjwala
    Balis, Dainius A.
    Desai, Mehul
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2017, 10 : 47 - 55
  • [38] Lipoprotein abnormalities in patients with type 2 diabetes and metabolic syndrome
    Dickson-Humphries, Tania
    Bottenberg, B.
    Kuntz, Susan
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2013, 26 (07): : 13 - 18
  • [39] The metabolic syndrome in type 2 diabetes: When does it matter?
    Wong, J.
    Molyneaux, L.
    Constantino, M. I.
    Twigg, S. M.
    Yue, D. K.
    DIABETES OBESITY & METABOLISM, 2006, 8 (06) : 690 - 697
  • [40] Management of Dyslipidemias in the Presence of the Metabolic Syndrome or Type 2 Diabetes
    Matikainen, Niina
    Taskinen, Marja-Riitta
    CURRENT CARDIOLOGY REPORTS, 2012, 14 (06) : 721 - 731